Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07115927) titled 'pReOperative Dostarlimab and Novel Therapies in EndOmetrial Cancer' on Aug. 4.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University College, London
Condition:
Endometrial Cancer
Intervention:
Drug: Dostarlimab
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: September 30, 2025
Target Sample Size: 40
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07115927
Published by HT Digital Content Services with permission from Health Daily Dig...